Lenalidomide and Ribavirin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lenalidomide (lenalidomide) and Ribavirin (ribavirin). Common drug interactions include kaposi's sarcoma among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Lenalidomide and Ribavirin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.



On Jul, 19, 2026

19 people who take Lenalidomide and Ribavirin together, and have interactions are studied.

Lenalidomide and Ribavirin drug interactions.

What are the common drug interactions of Lenalidomide and Ribavirin, by gender? *:

female:

  1. Kaposi's sarcoma (a tumour caused by human herpes virus)
  2. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  3. Human herpesvirus 8 infection
  4. Infection reactivation
  5. Papule
  6. Septic shock (shock due to blood infection)
  7. Skin lesion
  8. Renal impairment (severely reduced kidney function)
  9. Anaemia (lack of blood)
  10. Drug ineffective

male:

  1. Pneumonia
  2. Bacteraemia (presence of bacteria in the blood)
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Diarrhoea
  5. Dysgeusia (disorder of the sense of taste)
  6. Fatigue (feeling of tiredness)
  7. Neuropathy peripheral (surface nerve damage)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Drug ineffective

What are the common drug interactions of Lenalidomide and Ribavirin, by age (0-1 to 60+)? *:

0-1:

  1. Guillain-barre syndrome (the body's immune system attacks its peripheral nervous system)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  3. Diarrhoea
  4. Drug ineffective
  5. Dysgeusia (disorder of the sense of taste)
  6. Fatigue (feeling of tiredness)
  7. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  8. Hypoxia (low oxygen in tissues)
  9. Infection
  10. Neutropenia (an abnormally low number of neutrophils)

60+:

  1. Kaposi's sarcoma (a tumour caused by human herpes virus)
  2. Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
  3. Hepatitis e
  4. Pneumonia
  5. Human herpesvirus 8 infection
  6. Infection reactivation
  7. Papule
  8. Septic shock (shock due to blood infection)
  9. Skin lesion
  10. Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 11 people, 57.89%
  2. Kaposi's Sarcoma (a tumour caused by human herpes virus): 6 people, 31.58%
  3. Paraproteinaemia (normal or abnormal plasma protein appearing in large quantities): 6 people, 31.58%
  4. Gastrointestinal Amyloidosis (amyloid deposits along your gastrointestinal (gi) tract slow down the muscle contractions): 6 people, 31.58%
  5. Renal Amyloidosis (deposit of amyloid in kidney): 6 people, 31.58%
  6. Thyroid Cancer: 3 people, 15.79%
  7. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 3 people, 15.79%
  8. Bone Marrow Conditioning Regimen: 3 people, 15.79%
  9. Pneumonia Respiratory Syncytial Viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children): 3 people, 15.79%
  10. Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 10.53%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and Ribavirin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lenalidomide and Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide and ribavirin (the active ingredients of Lenalidomide and Ribavirin, respectively), and Lenalidomide and Ribavirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: